| Name | Title | Contact Details |
|---|
Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson`s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome. And in early-stage clinical research, we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. These communications may appear legitimate due to an official-looking Acadia email address or website, referencing of an actual recruiter and/or manager at Acadia (easily found on LinkedIn), and/or offer documents falsely signed by an Acadia executive. The impostor uses the incentive of a job interview and job offer to solicit sensitive personal information from the intended victim. Please note that the Acadia Talent Acquisition and HR Team will ONLY interact with a candidate from "Acadia-pharm.com" domain sourced emails. We do not request sensitive personal information, such as a Social Security Number, or payments of any kind during the interview or job offer process. Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication`s legitimacy. If in doubt, please contact talentacquisition@acadia-pharm.com to verify.
Wayne Pharmacy is a Wayne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St. Mary`s Health Care System is a not-for-profit Catholic health care provider whose mission is to be a compassionate healing presence in the communities we serve. Founded in 1906 and sponsored by the Sisters of Mercy, St. Mary`s Health Care System is built on a foundation of values that include excellence, compassion, integrity and reverence for each person. St. Mary`s focuses on neurosciences, cardiac care, orthopedics, general medicine/general surgery, women`s and children`s health, and gastroenterology. The system includes 196-bed St. Mary`s Hospital in Athens and 25-bed St. Mary`s Good Samaritan Hospital in Greene County. Services include emergency care, intensive care, home health care/hospice services, inpatient and outpatient rehabilitation, assisted living, Alzheimer`s/dementia care, preventive care, state-of-the art diagnostic and therapeutic care and a growing network of physician practices. Named Georgia`s Hospital of the Year in 2006 and 2010, St. Mary`s is proud to be the official health care provider for the University of Georgia Athletic Association. St. Mary`s has earned the Joint Commission Gold Seal of Approval for advanced primary stroke care, advanced inpatient diabetes, heart failure care, knee replacement surgery and spine surgery.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Access Therapies is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.